When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Renal tubular acidosis

Last reviewed: 22 Nov 2024
Last updated: 21 Dec 2021

Summary

Definition

History and exam

Key diagnostic factors

  • presence of risk factors
  • growth retardation
  • muscular weakness
  • failure to thrive (children)
  • hypoglycaemia after fructose ingestion
  • rickets
  • ethnicity/national origin
  • nephrolithiasis
Full details

Other diagnostic factors

  • sensorineural hearing loss
  • liver dysfunction
  • osteopenia, osteopetrosis, nephrocalcinosis, and cerebral calcifications
  • nephrocalcinosis
  • Kussmaul's breathing
  • ocular abnormalities (cataracts, glaucoma, band keratopathy), growth retardation, impaired intellect, calcification of basal ganglia
Full details

Risk factors

  • childhood
  • urinary tract obstruction
  • diabetes mellitus
  • primary biliary cirrhosis
  • nephrocalcinosis
  • nephrolithiasis
  • amphotericin-B therapy
  • toxic exposure to heavy metals, and cis-platinum
  • untreated primary adrenal insufficiency
  • family history of inherited RTA
  • older men
  • hereditary fructose intolerance
  • Wilson's disease
  • galactosaemia
  • disorders of mitochondrial metabolism
  • glycogen storage diseases
  • tyrosinaemia
  • Lowe syndrome
  • lead exposure
  • cadmium exposure
  • ifosfamide therapy
  • cystinosis
  • cyclosporine therapy
  • angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blocking drugs
  • heparin therapy
  • medications interfering with sodium transport
  • use of carbonic anhydrase inhibitors
  • abnormalities of filtered immunoglobulins
  • interstitial nephritis
  • hyperparathyroidism
  • environmental exposure to aristolochic acid
  • Thai or southeast Asian ancestry
  • cis-platinum therapy
  • toluene, paraquat, lysol exposure
  • Dent's disease
  • ibuprofen overdose
  • lamivudine
  • antiviral therapy (cidofovir, adefovir, or tenofovir)
  • programmed cell death protein 1 (PD-1)-inhibitors
Full details

Diagnostic investigations

1st investigations to order

  • serum bicarbonate
  • serum chloride
  • serum sodium
  • serum potassium
  • arterial blood pH
  • serum anion gap
  • urine pH
Full details

Investigations to consider

  • serum aldosterone
  • urine anion gap
  • measurement of fractional bicarbonate excretion
  • urine PCO₂ bicarbonate infusion
  • furosemide test
  • ammonium chloride loading test
  • furosemide and fludrocortisone test
  • urine glucose
  • tubular maximum (Tm) reabsorption of phosphate
  • fractional excretion of amino acids
  • ultrasound
  • CT/spiral CT
  • nuclear renal scan
Full details

Emerging tests

  • molecular genetic testing for hereditary distal RTA (type I)

Treatment algorithm

ONGOING

classic distal RTA (type I)

proximal RTA (type II) including Fanconi syndrome

mixed proximal and distal DTA (type III)

hyperkalaemic distal RTA (type IV) + mineralocorticoid deficiency

hyperkalaemic distal RTA (type IV) + mineralocorticoid-resistant

Contributors

Authors

Ashish Verma, MBBS

Assistant Professor of Medicine

Section of Nephrology

Department of Medicine

Boston University School of Medicine/Boston Medical Center

Boston

MA

Disclosures

AV declares that he has no competing interests.

Acknowledgements

Dr Ashish Verma would like to gratefully acknowledge Dr Melvin E. Laski, Dr Elizabeth Cobb, Dr Rebin Titus, and Dr Abeer Kaldas, previous contributors to this topic.

Disclosures

MEL, EC, and AK declare that they have no competing interests; RT's competing interests are not disclosed.

Peer reviewers

Daniel Batlle, MD

Professor

Northwestern University

Evanston

IL

Disclosures

DB declares that he has no competing interests.

Troels Ring, MD

Department of Nephrology

Aalborg Hospital

Aalborg

Denmark

Disclosures

TR declares that he has no competing interests.

Use of this content is subject to our disclaimer